UNSPSC 51286600: Antibacterial pyridines

This classification denotes antibacterials that have a benzene-like structure (C5H5N).

UNSPSC 51286600 Antibacterial pyridines is a Class code that describes pharmaceutical and medical supply procurement, though recent state and local activity under this code centers on naloxone, drug deactivation systems, emergency medical supplies, and generic pharmaceuticals rather than pyridine-specific compounds. State and local governments buying under this code are acquiring naloxone and overdose-response products, emergency medical and first aid consumables for fire and rescue services, and generic multi-source pharmaceuticals and over-the-counter products distributed through authorized pharmacy networks. Issuing bodies include county health departments (Seminole County, Florida), city fire departments (City of Tampa), state health and human services commissions (Texas HHS), and multistate cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance, or MMCAP, serving Minnesota and Oregon). The mix reflects both direct-purchase and cooperative-purchasing procurement models, with state agencies and local health and fire departments as primary buyers.

Recent opportunities span Florida, Texas, and the Upper Midwest. Seminole County, Florida posted IFB 60459723LAS in June 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with a July 26, 2023 response date and a two-year initial term with one-year renewal option. The City of Tampa released IFB 26P00145 in March 2026 for medical and first aid supplies (169 line items including respiratory equipment, cardiac monitoring electrodes, bandaging, and oxygen delivery systems) with a due date of March 13, 2026, an estimated contract value of $700,000.00, and a one-year award term with two one-year renewal options; this procurement is sheltered for certified Small Local Business Enterprises with a 5 percent bid discount up to $10,000. Texas HHS issued RFI HHS0017013 in April 2026 to explore direct-to-manufacturer prescription programs with a response deadline of April 3, 2026. MMCAP posted RFP S1070000015802 in January 2026 for generic multi-source pharmaceuticals and OTC products with a March 26, 2026 proposal deadline, requiring vendors to work with three authorized wholesalers (AmerisourceBergen, Cardinal Health, Morris & Dickson) and comply with cGMP and Drug Supply Chain Security Act standards.